Showing results (381-390 of 1,401) with videos related to
Sort By:
Pageof 141
Biological Psychiatry|July 1, 1995
Decreased DOPAC in the anterior cingulate cortex of individuals with schizophreniaR J Wyatt, F Karoum, M F CasanovaEuropean Journal of Pharmacology|August 15, 1977
The dynamics of dopamine metabolism in various regions of rat brainF Karoum, N H Neff, R J WyattThe Journal of Clinical Psychiatry|June 1, 1983
Improving accuracy in the diagnosis of Alzheimer's diseaseD Shore, C A Overman, R J WyattEuropean Journal of Pharmacology|July 16, 1982
Different effects of behaviorally equipotent doses of amphetamine and methamphetamine on brain biogenic amines: specific increase of phenylethylamine by amphetamineL W Chuang, F Karoum, R J WyattBehavioural Pharmacology|April 26, 2000
SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphineJ M Masserano, F Karoum, R J WyattPsychiatry|January 1, 1996
New directions in the prevention and treatment of schizophrenia: a biological perspectiveR J Wyatt, J A Apud, S PotkinEuropean Journal of Pharmacology|March 11, 1994
Selective reduction in dopamine turnover in the rat frontal cortex and hypothalamus during withdrawal from repeated cocaine exposureF Karoum, M F Egan, R J WyattPsychopharmacology|January 1, 1983
The time and space machine: continuous measurement of drug-induced behavior patterns in the ratD M Stoff, K Stauderman, R J WyattPsychiatry Research|December 1, 1989
Binding of 3H-spiperone to human peripheral lymphocytes: absence of stereospecific high-affinity bindingA Feenstra, M A Coggiano, R J WyattEuropean Journal of Pharmacology|April 13, 1988
Chronic cocaine effects on peripheral biogenic amines: a long-term reduction in peripheral dopamine and phenylethylamine productionF Karoum, R W Fawcett, R J WyattPageof 141